Merocel Surgicel Wrap Technique to Manage Diffuse Epistaxis in Patients with Comorbidities

Table 2

Patient clinical data.

Pt. number	Age	Sex	Risk factor	Anticoagulation use	Site	Pain (out of 10)	Previous epistaxis	Complication
1	8	Male	None	Yes	Unilateral	N/A	Yes	Rebleeding
2	65	Male	HTN	No	Bilateral	6	Yes	None
3	72	Male	Cardiac/HTN	Yes	Bilateral	6	Yes	None
4	51	Male	Cardiac/HTN	Yes	Bilateral	N/A	Yes	None
5	68	Male	DM/HTN	Yes	Bilateral	5	Yes	Non
6	48	Male	HTN	Yes	Bilateral	N/A	Yes	None
7	76	Male	Cardiac/HTN	Yes	Bilateral	6	Yes	Non
8	56	Male	HTN	Yes	Unilateral	7	Yes	None
9	100	Male	HTN	Yes	Bilateral	N/A	Yes	None
10	19	Female	Renal failure	Yes	Bilateral	7	Yes	None
11	53	Female	DM/HTN	Yes	Bilateral	8	Yes	None
12	57	Female	Cardiac/HTN	Yes	Bilateral	5	Yes	None
13	33	Male	Cardiac	Yes	Bilateral	4	Yes	None
14	89	Male	DM/HTN	Yes	Yilateral	6	Yes	None
15	64	Male	Cardiac/HTN	Yes	Bilateral	N/A	Yes	None
16	40	Male	Renal failure	Yes	Bilateral	5	Yes	None
17	59	Female	DM/HTN	Yes	Unilateral	4	Yes	None
18	72	Male	DM/HTN	No	Unilateral	5	Yes	None
19	60	Female	DM/HTN	Yes	Bilateral	6	Yes	None
20	55	Male	HTN	No	Bilateral		Yes	None
21	85	Female	Cardiac DM/HTN	Yes	Bilateral	N/A	Yes	None
22	61	Male	HTN	Yes	Bilateral	5	Yes	None
23	79	Male	Renal failure	Yes	Unilateral	4	Yes	None
24	77	Female	DM/HTN	Yes	Bilateral	6	Yes	None
25	58	Female	DM/HTN	Yes	Bilateral	6	Yes	None

N/A: for patients either in coma or intubated and sedated; DM: diabetes mellitus; HTN: hypertension.